Fig. 2

Proportion of CADM1, MAL, or miR124-2 methylation markers testing positive within precancers defined by both cervical intraepithelial neoplasia (CIN) grading (a) and immunoscore grading (b)

Proportion of CADM1, MAL, or miR124-2 methylation markers testing positive within precancers defined by both cervical intraepithelial neoplasia (CIN) grading (a) and immunoscore grading (b)